Mitsukoshi Health and Welfare Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
1994
NCT00211705
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1994

Timeline

NOW
  • Now

Alternative names

Mitsukoshi Health and Welfare Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

pravastatin (pravachol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 4)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1